Palliative Care: Multidimensional Challenges in Patients with Severe Chronic Illness
Jochanan E. Naschitz*
Bait Balev Nesher, Department of Comprehensive Nursing and Palliative Care, and The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel
*Corresponding author: Jochanan E. Naschitz, Bait Balev Nesher, Department of Comprehensive Nursing and Palliative Care, and The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel. Tel: + 972-0732377300; Fax: + 972-48345575; Email: Naschitz@technion.ac.il
Received Date: 03 August, 2019; Accepted Date: 15 August, 2019; Published Date: 23 August, 2019
Citation: Naschitz JE (2019) Palliative Care: Multidimensional Challenges in Patients with Severe Chronic Illness. Curr Trends Intern Med 3: 125. DOI: 10.29011/2638-003X.100025
Abstract
Palliative medicine provides symptomatic care to patients suffering from serious chronic illnesses and offers psychological support to both patients and their families. Palliative care has been historically the main or only therapy assigned to patients with advanced cancer. In the present, palliative care has become an important adjuvant in cancer care along the long trajectory of disease management. Symptomatic long-term palliative care has its place in the management of advanced heart failure, respiratory failure, liver failure, renal failure and multi organ failure. Even in the most limited sense palliative care is demanding. Yet, caring for patients with severe chronic diseases, involves challenges beyond the strict discipline of palliative medicine. Consideration is needed for the gamut of problems for which the general physician might not be prepared or skilled, and which might require expert consultation and expert management. The complexity and variety of situations faced by physicians in palliative/hospice care is illustrated by ten case histories presented in the following. Palliative care is never simple. It is often propelled by multidimensional challenges.
Keywords: Cancer; Hospice Care; Palliative Medicine
1. Introduction
By definition
palliative care provides symptomatic care and psychological support to patients
suffering from serious chronic illnesses. Palliative care is no longer
synonymous with end of life care, rather in many cases palliative care is
instituted together with curative interventions during the course of severe
chronic diseases. This shift in the implementation of palliative care has been
largely acknowledged [1,2]. Palliative care is indicated for patients with
cancer and, also, for persons suffering from advanced heart failure,
respiratory failure, liver failure, renal failure, multi organ failure or
chronic pain syndromes. A variety of symptoms is addressed during palliative
care, and comprise pain, shortness of breath, delirium, depression, insomnia,
nausea, vomiting, constipation, and pruritus.
The term hospice
care is used to describe a specific model of palliative care offered to
patients who are at the end of life with terminal disease, when curative or
life-prolonging therapy no longer provides the focus of treatment. Yet, even in
the extreme situation of patients assigned to hospice care, end of life is not
necessarily imminent. Under the same diagnosis, the same disease, and with
similar prognosis according to guidelines, the course of the patients' disease
may differ. Hence, treatment should be tailored according to the patient's
factual condition, which may be consistent or inconsistent with statistical
data provided by evidence-based medicine.
Meeting the goals of
palliative care, in their limited sense, is demanding, yet many other
challenges can present. The variety of problems faced by physicians at the
bedside is illustrated in case histories from our recent experience. The
challenges were so very different and comprised paraneoplastic postural
hypotension, brittle diabetes mellitus secondary to pancreatectomy, central
diabetes insipidus, feeding intolerance, drug-induced tardive dyskinesia,
sepsis associated encephalopathy, and priapism. Awareness and consideration are
warranted in coping with problems outside the strict discipline of palliative
medicine. Expert consultation and expert management might be required. In
practice, palliative care is never simple and often complicated by
multidimensional challenges.
2. Case Histories
Case 1: Post-pancreatectomy
postural hypotension and brittle diabetes mellitus. A 74-year-old woman
diagnosed with adenocarcinoma of the head of the pancreas underwent total
pancreatectomy, splenectomy and gastrectomy with Roux-en-Y
esophago-enterostomy. Metastases to the omentum were present. She received
chemotherapy according to the FOLFOX protocol. Diabetes mellitus developed
after pancreatectomy. She was treated with insulin glargine and insulin
glulisine as well as high dose of oral pancreatin. Though PET- CT showed no
evidence of remnant disease, the patient was weak and fainted several times.
Her blood sugar was difficult to control with repeated episodes of
hypoglycemia. Soon it became apparent that the patient had severe orthostatic
hypotension. The onset of postural symptoms was recent, and her family
physician and oncologist were unaware of hypotension. During postural challenge
(Figure 1) there was severe decrease of the blood pressure without compensatory
tachycardia - a finding consistent with neurogenic orthostatic hypotension.
Diabetic autonomic neuropathy or paraneoplastic autonomic neuropathy were
considered among the possible causes [3,4].
Treatment of
postural hypotension was initiated with a high salt diet combined with the
vasoconstrictor midodrine (titrated to 20 mg/day) and fludrocortisone 0.2
mg/day. Good control of hypotension was achieved (Figure 2) without further use
of elastic bandages.
More difficult to
control was the post-pancreatectomy diabetes mellitus. Diabetes mellitus
secondary to total pancreatectomy, which is insulin dependent like type I
diabetes mellitus, however, differs very much from type I diabetes. Patients
with total pancreatectomy lack not only insulin, but also glucagon, the counter
regulatory hormone to insulin and therefore are prone more to hypoglycemia
under insulin treatment [5]. In a study comparing the two conditions, the basal
insulin in total pancreatectomy was as low as 3.7 units/day, which was less
than one‐third the dose
required in type 1 diabetes. The prandial insulin dose of insulin was similar.
Brittle diabetes after total pancreatectomy is best treated by continuous
insulin delivery [6].
During the 5-month
hospitalization in our ward the patient lost 1 kg in weight but felt better.
Postural hypotension is controlled. Glycemia is difficult to control but there
were no hypoglycemic events. Further courses of FOLFOX treatment have been
scheduled.
Case 2: Cholangiocarcinoma
- complications of disease and complications of treatment A 76-year-old woman
was admitted for post-acute care having recovered after a minor stroke. Until
recently she had been mentally and physically well, having just returned from
the Far East. But her medical history was laden with disease:
cholangiocarcinoma diagnosed in 2015, four years prior to the current
admission. There had been remission of the symptoms after resection of left
hepatic lobe followed by chemotherapy. When the disease recurred in 2017
fluoropyrimidine-based Selective Internal Radiation Therapy (SIRT) with
yttrium-90 resin microspheres was provided. In 2018 low-SAAG ascites occurred
needing repeated large volume paracentesis. The patient's history comprised
type 2 diabetes mellitus, that recently had become difficult to control, and
peripheral neuropathy that might have been a complication of the diabetes or
chemotherapy. On admission to our ward the blood pressure was 112/56 mmHg. The
abdomen was distended with shifting dullness. The hemoglobin was 7.2 g/dL,
platelets 65000/mm3, serum albumin 2.6 g/dL, eGFR 71 ml/min/1.73m2
(within normal range). The patient's daily medication comprised spironolactone
100 mg, furosemide 40 mg, insulin glargine 30 U, postprandial insulin
glulisine, metformin 1700 mg and 800 U vitamin D3. To avoid tense ascites,
paracentesis was performed at 14-day intervals, removing 3.5 - 4 litre of
fluid, without the need for i.v. albumin replacement. Subsequently, episodes of
delirium occurred, rising suspicion of hepatic encephalopathy. The presence of
high serum ammonia supported the diagnosis. Treatment with lactulose and
rifaximin was beneficial.
When frequent
vomiting intervened, the cause remaining obscure, metoclopramide 5 to 10 mg was
administered as needed. Vomiting subsided after two weeks and metoclopramide
was discontinued. However, there was neurologic deterioration manifesting as
dyskinesia and delirium. Stereotypic movements of the mouth, tongue twisting
and protrusion, grimacing, writhing movements of the trunk and choreoathetosis
movements of the fingers were observed. Tardive dyskinesia was diagnosed,
possibly metoclopramide-induced, though the exposure to the drug was short and
the dose small, not exceeding current recommendations [7]. Beside
metoclopramide, other causes of dyskinesia were excluded on cerebral CT and
cerebrospinal fluid examination.
Tardive dyskinesia
is an involuntary movement disorder caused by chronic exposure to dopamine
receptor antagonists and resulting in the upregulation of the dopamine
receptors in the basal ganglia and damage to striatal cholinergic neurons.
Tardive dyskinesia occurs most frequently after prolonged treatment with
dopamine antagonists, particularly antipsychotic drugs or metoclopramide [7].
Therefore, it is currently recommended that metoclopramide treatment should not
exceed 3 months. However, tardive dyskinesia occasionally occurs after
short-term low-dose metoclopramide treatment [8], similar to the adverse
reaction observed in our patient. After discontinuation of the drug symptoms of
tardive dyskinesia can take months to resolve or may be irreversible. Currently
it is possible to successfully manage this condition with other agents approved
by the US Food and Drug Administration. Our patient was treated with biperiden
and later sulpiride [9]. Improvement was witnessed after 2 months of combined
treatment, the patient being able to eat and drink, but dyskinesia remained
prominent 6 months after its onset.
This patient
presented with numerous complications of the disease and treatment, and needed
multi-disciplinary diagnostics and management. The diagnoses included
SIRT-induced liver fibrosis, portal hypertension, ascites, portal vein
thrombosis, hepatic encephalopathy, hepato-renal syndrome and
metoclopramide-induced tardive dyskinesia. Six months after her admission to
our ward the patient's condition remains stable at a very low level of
function, necessitating continuing comprehensive nursing and medical care.
There is no evidence of recurrence of the malignant neoplasm.
Case 3: Cholangiocarcinoma,
feeding intolerance, entero-cutaneous fistula, fluid-electrolyte imbalance A
68-year-old man was admitted for supportive care between courses of FOLFIRI
regimen (consisting of Folinic Acid (Leucovorin)-Fluorouracil-Irinotecan) for
metastatic cholangiocarcinoma. Four years earlier he underwent left lobe
hepatectomy followed by chemotherapy. Remissions and recurrences alternated.
Lately, an entero-cutaneous fistula emerged draining 2 to 3 liters of turbid
fluid. High dose loperamide was administered. By increasing the transit time of
the intestinal contents loperamide reduces fecal volume and decreases the loss
of electrolytes and fluids. In this patient, loperamide was of no avail.
Feeding intolerance
became a problem and was initially attributed to impaired gastric emptying. A
gastro-duodenal stent was inserted. However, the patient continued to feel
discomfort after ingestion of food, suffered nausea and regurgitated or
vomited. Feeding intolerance may be caused by gastrointestinal disorders,
visceral pain, sepsis, chemotherapy (by affecting the cerebral chemoreceptor
trigger zone), increased intracerebral pressure, gastric obstruction or
gastroparesis. In the propositus, CT showed no obstruction and documented
normal gastric emptying. First line treatment with metoclopramide for
functional feeding intolerance was instituted but proved disappointing. Indeed,
feeding intolerance constitutes an unmet therapeutic challenge [10].
Parenteral nutrition
(1700 ml) was instituted. Aggressive correction of hypovolemia and electrolyte
loss was provided as recommended for high output fistulas [11]. Dehydration was
prevented by replacing fluid losses. Monitoring the volemia and diagnosing
dehydration is not as simple as it might seem. No single clinical or laboratory
parameter is satisfactory in diagnosing dehydration, neither serum osmolality,
hematocrit, serum sodium, nor the BUN: creatinine ratio. Useful is the daily
examination of the patient by the same physician, daily assessment of the fluid
balance, with conventional ‘laboratory markers of dehydration’ serving as
corroboration [12]. In adhering to this rule, the nutrition, fluid and
electrolyte status of the patient was appropriate while he continued receiving
chemotherapy.
Case 4: Sepsis-associated
encephalopathy A 78-year-old man was transferred to our institution for long-term
nursing care and life support. Until recently he had been fit and in good
cognitive state until recently, with reasonably controlled arterial
hypertension and diabetes mellitus. Having suffered a non-traumatic cerebral
hemorrhage, mechanical ventilation was instituted, a subdural hematoma was
drained and a ventriculoperitoneal shunt was inserted. Within a couple of
weeks, the patient recovered from the vegetative state. At the time of
admission to our ward he was in stable hemodynamic condition, following
tracheostomy and enteral feeding, alert but unable to undergo the mini-mental
state examination. The medications comprised insulin glulisine and glargine,
amlodipine, carbidopa-levodopa and vitamin D. During two-years of care in our
department the patient suffered from repeated infections: urinary tract
infections, epididymitis, pressure sores complicated by osteomyelitis, and
pneumonias. Each event was heralded by lethargy; the temperature rose to
38.2-38.8 and the white blood cells up to 12.000/mm3. As a rule,
antibiotic treatment was started within 4 hours of onset of the symptoms. All
incident infections were associated with neurocognitive decline, sometimes as
low as the minimal conscious state, variably lasting 7-20 days. Recovery from
infection was followed by improvement of cognition. The serum sodium,
potassium, calcium, magnesium, thyrotropin, folate and vitamin B12 levels
remained within the normal range. On cerebral CT no new lesions were noted, and
the ventriculo-peritoneal shunt was functioning. Sepsis-associated encephalopathy
was the likely diagnosis. Sepsis-associated encephalopathy is a diffuse brain
dysfunction secondary to infection outside the central nervous system. It is
mediated by pathogen-associated molecular patterns and inflammatory cytokines
which affect neurotransmission, impair mitochondrial and endothelial function,
and damage brain-cells. Sepsis-associated encephalopathy manifests with acute
alterations in memory, attention and concentration, that usually improve after remission
of the infection. No treatment for sepsis-associated encephalopathy has proven
efficacy [13,14].
The patient's
cognitive state was fluctuated under the effect of infection; improvement after
the remission of infection was sometimes delayed and incomplete. With cognition
at its lowest point, a minimal consciousness state + was diagnosed: the
patient's sleep-wake cycle was preserved along with comprehension of basic
language. Emergence was apparent when the patient became functionally able to
communicate and use objects [15]. Over a two-year period, repeated infections
apparently had a cumulative negative effect on the patient's cognition. While
sepsis-associated encephalopathy is usually transient and self-limited, under
repeated or persistent systemic inflammation the cognitive and behavioural
changes may become permanent [16].
Diagnosing
sepsis-associated encephalopathy is challenging, especially with a background
of chronic illnesses. Fever may be absent in frail elderly persons along with
paucity of other signs of infection [17]; therefor, infection should be
considered in the presence of new or increasing confusion, incontinence,
falling, deteriorating mobility, reduced food intake, or failure to cooperate.
Furthermore, a patient being treated with glucocorticoids when contracting an
infection may have a blunted febrile response. Exclusions before diagnosing
sepsis-associated encephalopathy should include hepatic, uremic, or respiratory
encephalopathy, metabolic disturbances, drug overdose, withdrawal of sedatives
or opioids, alcohol withdrawal delirium, Wernicke's encephalopathy and a
variety of central nervous system disorders. Brain imaging may aid in the differential
diagnosis.
Diagnosing and
treating sepsis-associated encephalopathy are equally challenging. Most
treatment schemes are geared toward treating the symptoms of delirium. None of
the therapies that aim to treat the pathophysiological mechanisms of
sepsis-associated encephalopathy have been proven effective in humans. It is
reasonable, yet unproven, to presume that early initiation of antibiotic
treatment might benefit cognitive recovery.
Case 5: The Post Intensive
Care Syndrome (PICS) A 62-year-old woman was admitted for post-acute care after
cardiac surgery. Until recently she had been living independently in the
community. Her medical history comprised congestive heart failure, severe
mitral and aortic regurgitation, pulmonary hypertension chronic atrial
fibrillation, and type 2 diabetes mellitus. After open heart surgery -
replacement of the mitral and tricuspid valves and closure of the left atrial
appendage - the hospital course was complicated by pneumonia, sternal
osteomyelitis, difficult weaning from mechanical ventilation and neurocognitive
impairment. On admission to our institution she was mechanically ventilated.
Her medications were TMP\SMX (160/800 mg), warfarin, bisoprolol, escitalopram,
clonazepam, sildenafil, vitamin D and calcium gluconate, transcutaneous
fentanyl, and inhalations with ipratropium. The prominent challenges in the
management of this patient were delirium, severe cognitive impairment, stance
and gait disorder, difficult weaning from mechanical ventilation and problematic
control of warfarin treatment. Her consciousness was impaired, she was often
apathetic, attention was easily distracted; at times she was agitated with
delusions. During lucid intervals, the mini mental test scored MMSE 17/30, MOCA
13 (normal >24), clock drawing 3/5. Her stance was unsteady. She was able to
take but a few steps using a walker and under supervision.
Among causes of the
patient's neurocognitive deterioration, stroke, encephalitis and head trauma
were excluded. Delirium is a common feature of subdural hematoma and may be
mistakenly ascribed to infection or medication. A fall without head injury may
account for up to 54 per cent of patients with subdural hematoma and there may
be a long delay between a fall or trauma and the onset of the symptoms (range
15 to 751 days) [18]. The patient, being on warfarin treatment, was at
increased the risk for subdural hematoma [19]. For these concerns a repeat
cerebral CT was performed which excluded subdural as well as cerebral bleeding.
Medication is often
the cause of delirium, particularly anxiolytics (the patient received
escitalopram and clonazepam), antidepressants, opioids (the patient was treated
with transdermal fentanyl), antiparkinsonians, antiepileptics, cardiovascular
medications, antihistamines, corticosteroids, sedative-hypnotics, and drugs of
abuse (alcohol, cannabis, cocaine). Considerable resources are sometimes
expended before a newly administered drug is recognized as the cause of the
delirium [20]. Trimethoprim–Sulfamethoxazole (TMX/SMX), which the patient was
receiving, can cause various adverse neurologic events: aseptic meningitis,
delirium and gait disturbances. Neurologic symptoms that occur within days of
continuous treatment usually resolve following discontinuation of TMX/SMX. We
discontinued TMX/SMX, but no improvement of cognition, stance and delirium was
witnessed. Six weeks later, in another sequence of events, TMP/SMX treatment
was reinstituted; there were no deleterious consequences, on the contrary,
cognition and stance were improving at this time and the patient was free of
delirium.
It is not clear how
long delirium lasts [21,22]. A study of patients suffering from delirium while
hospitalized in a general medical ward found that in 70% of the cases delirium resolved
by day 7. In another study, including elderly patients with delirium after hip
fractures in 75% of the cases the delirium resolved by day 5. Delirium affects
up to three quarters of patients after cardiac and non-cardiac surgery.
Although delirium may resolve during hospitalization, delirium may have
long-term functional and cognitive consequences. Since patients with
postoperative delirium continue to have improvements in cognitive function up
to 6 months after surgery, rehabilitation services may need to be extended for
these patients [21].
Cognitive impairment
after critical illness is very common and, in some patients, persists longer
than a year. The Post-Intensive Care Syndrome (PICS) is diagnosed as a new or
worsening function after critical illness affecting one or several of the
following domains: cognition, psychiatric function, physical function. The
memory and executive function are the most often affected domains, and often
hinder a person from engaging in goal-directed behaviours that are necessary in
effective daily functioning. Other common symptoms are weakness, poor mobility,
poor concentration, fatigue, anxiety, and depressed mood. Commonly cited risk
factors for the development of PICS are pre-existing illnesses (neuromuscular
disorders, dementia, psychiatric illness) as well as ICU-specific factors
(mechanical ventilation, delirium, sepsis, acute respiratory distress
syndrome). The signs and symptoms of PICS improve modestly over the first 6 to
12 months following discharge from the ICU. However, in many patients, deficits
persist for years. The effect of preventive or therapeutic interventions on
PICS outcome is unknown [22]. PICS-family is the term used when critical
illness of a loved one adversely affects the mental health of family members.
This patient
recovered cognitively, her stance and gait improved, being weaned from
mechanical ventilation and discharged home only eight months after cardiac
surgery. Though PICS is not a new entity, it is not listed among the etiologies
of acute onset dementias. PICS deserves awareness as well as long time
rehabilitation.
Case 6: Lasting oral
dysphagia and pressure ulcer after stroke A 58-year-old man was admitted to our
ward with a large stage 4 pressure ulcer on the right heel. Adjacent to the
pressure ulcer calcaneal osteomyelitis had been diagnosed. Before referral to
our ward he had completed 6 weeks of antibiotic treatment. The patient’s
medical history included morbid obesity (his usual body weight was 140 kg,
height 178 cm), type 2 diabetes mellitus, arterial hypertension and
hypercholesterolemia. Two years before admission he had an ischemic stroke with
right hemiplegia and aphasia. Thereupon, he had difficulty in swallowing and
lost weight. He was unable to swallow the medications prescribed, including
bisoprolol fumarate, enalapril, aspirin, glucosamine and omeprazole. On
admission to our ward he was alert and communicated non-verbally. He was
manifestly wasted. The present body weight was 67 kg. The body temperature,
blood pressure and SpO2 were normal. The body temperature, the
previously elevated leukocyte and C reactive protein had returned to normal. He
had facial weakness, delayed initiation of swallowing, piecemeal swallows and
oral spill. Repeated trials to swallow were needed for satisfactory clearance
of the ingested food (Figure 3). Cough sometimes followed. These features were
consistent with oral dysphagia. A structural cause of oral dysphagia could be
excluded by CT and fiberoptic endoscopy, such as Zenker's diverticulum, a
neoplasm, osteophytes and cervical web. Signs of generalized muscle weakness
were absent. Cerebral CT showed numerous old infarctions and severe cerebral
atrophy. In the context of stroke preceding the dysphagia, the diagnosis of
oral neurogenic functional dysphagia was proposed.
Normal swallowing
necessitates the coordinated, synergic and progressive action of the lingual
and pharyngeal muscles. The movements of the tongue upward and backward propel
the bolus into the pharynx under volitional control. Hemispheric strokes may
disrupt the control of oral bolus preparation and propulsion [23]. Dysphagia is
a common problem after stroke. In many cases, dysphagia resolves quickly, but
in others dysphagia persists. Dysphagia rehabilitation comprises manipulation
of the food consistency along with techniques aimed to improve the strength and
coordination of the orofacial musculature [24,25]. Helpful techniques are the
chin tuck, head turn, Mendelsohn’s maneuver and tongue strengthening exercises.
In the present case, though rehabilitation was started late, the swallowing
improved remarkably. Though piece meal swallowing persisted, propelling the
food became efficient the patient finishing the meals in 5 out of 6 instances.
There was neither aspiration nor nasal regurgitation. He gained weight from 67
kg on admission to 92 kg after 14 months. The serum albumin increased to 3.8
g/dL. In parallel, over a period of 3 months the pressure ulcer healed.
Insufficient dietary
intake is among the key risk factors for the development of pressure ulcers and
delayed wound healing [26] and, probably, was a major contributor to impaired
wound healing in this patient. Unless patients can swallow, enteral or
parenteral nutrition is required to prevent an energy deficit that rapidly
leads to wasting and pressure injury [27]. Malnutrition should be corrected and
nutritional markers, such as albumin and prealbumin, be followed. When the
patient becomes able to swallow, high-protein oral supplements are effective in
reducing the incidence of pressure ulcers [28]. The American College of
Physicians recommends protein or amino acid supplementation in patients with
pressure ulcers [29]. Usually, patients with stage III and IV pressure ulcers
should receive at least 30 kcal/kg/day to promote wound healing. Increased
dietary protein intake also fosters healing of pressure ulcers. The protein
target typically is 1.5 g/kg/day. Specific amino acids such as arginine,
glutamine, and β-hydroxy β-methylbutyrate can be added to oral/enteral foods to
accelerate healing [30]. Abound ®, a nutritional supplement containing
arginine, glutamine and beta-Hydroxy Beta-Methylbutiric Acid (HMB), has been
claimed to improve wound healing: the recommended dose is arginine 3 -
4.5g/day. However, evidence still remains inadequate to support the role of
these agents in prevention or healing pressure ulcers [28]. Contrasting with
this data, a 2014 Cochrane review found no clear evidence that dietary
supplementation reduces the number of people who develop pressure ulcers or
help the healing of existing pressure ulcers [29]. In our routine we conform to
the principle of high calorie and high-protein nutrition; this proved to be
favorable in the present case.
Swallowing
rehabilitation improved the intake of food, permitted high calorie-high protein
ingestion, improved the patient’s nutritional status and promoted healing of the
refractory pressure ulcer.
Case 7: Missed diagnosis of
diabetes insipidus A 46-year-old man was transferred to our ward for life
support and palliative care after suffering a traumatic head injury, subdural
hemorrhage, cardiac arrest and anoxic brain damage. He was in an unaware
wakefulness state, received respiratory care through tracheostomy and enteral
nutrition through gastrostomy. His medications were phenytoin sodium,
levetiracetam and bisacodyl. While hospitalized in neurosurgery, intensive care
and subsequently in our ward the diuresis was about 3000 mL/day. Hypernatremia
was a constant finding, in the range of 148-156 mEq/L. Spot urine osmolality
was 248 mOsm/L. This clinical setting - polyuria associated with hypernatremia
subsequent to traumatic brain injury - was suggestive of central diabetes
insipidus [31]. The diagnosis was confirmed on normalization of serum sodium,
serum osmolality and diuresis under desmopressin treatment. Desmopressin, a
synthetic analogue of the antidiuretic hormone, is the drug of choice for the
management of central diabetes insipidus. The ease of administration makes it a
preferred option for chronic treatment.
Polyuria has been
variously defined as urinary output >3000 mL/day, >2500/day, and 50 mL/kg
body weight/day. Polyuria-induced dehydration and hypernatremia may lead to
organ dysfunction and injury, primarily apparent in the central nervous system
and kidneys. Common causes of polyuria in older patients are compulsive water drinking,
diabetes mellitus, diuresis following relief of urinary obstruction, diuretic
treatment, and all should be considered in the differential diagnosis. Polyuria
is also caused by SGLT2 inhibitor treatment for type 2 diabetes mellitus [32].
Diabetes insipidus is a rare cause of chronic polyuria. It is the consequence
of decreased arginine-vasopressin (the antidiuretic hormone) secretion or of
peripheral resistance to antidiuretic hormone. According to a commonly used
algorithm useful in the diagnostic work-up of polyuria, urine osmolality
<100 mOsm/L suggests compulsive water drinking, urine osmolality 100-300 is
consistent with diabetes insipidus and urine osmolality >1200 mOsm/L is
caused by diuretic medication or glycosuria.
Central diabetes
insipidus is the result of absent or diminished antidiuretic hormone secretion;
administration antidiuretic hormone (the analogue desmopressin) will quickly
correct both polyuria and hypernatremia. By this, the diagnosis of central
diabetes insipidus is established. Nephrogenic diabetes insipidus shares
clinical features with central diabetes insipidus but is resistant to the
effect of desmopressin. A variety of disorders may injury the renal tubules
making them resistant to antidiuretic hormone. Such are urinary obstruction,
infection, severe hypokalemia, severe hypercalcemia and a variety of drugs.
Nephrogenic diabetes insipidus is not a rare condition, in distinction from
central diabetes insipidus. Treatment of nephrogenic diabetes insipidus should
be is tailored to the underlying disorder. The patients should be allowed free
access to oral hydration; those incapacitated should receive enteral or
parenteral fluid replacement matching the urine output [33].
Acute head trauma
can provoke dysfunction of the hypothalamic neurons inducing diabetes
insipidus. The disorder becomes apparent in the first days after the trauma and
is transient in most patients. In a minority of cases, post-traumatic diabetes
insipidus becomes permanent. In the differential diagnosis the main
consideration is compulsive water drinking. The diagnosis in our patient was
suggested by the clinical setting - polyuria associated with hypernatremia
after traumatic brain injury [31] - and was confirmed by normalization of the
serum sodium and diuresis under desmopressin treatment. Awareness of diabetes
insipidus, a treatable disorder, may be important though rarely met in
geriatric care.
Case 8: Thyroxine
pseudomalabsorption A 72-year old woman was admitted for treatment of venous
ulcers. Her medical background included arterial hypertension, chronic atrial
fibrillation, mild chronic renal failure, morbid obesity and hypothyroidism.
Her regular medications were furosemide, propafenone, diltiazem and
levothyroxine. She was alert and cognitively competent and her vital signs were
within the normal range. Unexpected among the routine laboratory tests were
high plasma TSH and low FT3 values, contrasting with previous appropriate
response to levothyroxine treatment (Table 1).
There was a
discrepancy between laboratory results and the absence of clinical symptoms of
hypothyroidism, such as fatigue, poor concentration, weight gain and
constipation. The acute worsening of the thyroid function assays shortly after
the patient’s admission in the absence of hypothyroid symptoms may be due to
laboratory error [34], levothyroxine malabsorption or "Pseudomalabsorption"
[35]. Patients should undergo a diagnostic work-up for levothyroxine
malabsorption when the TSH levels are persistently high while the patient is
receiving daily levothyroxine 2 μg/kg or more. In dubious situations, thyroxine
absorption testing is indicated with use of high-dose levothyroxine. But the
work-up begins with review of the patient’s medications since drugs may
interfere with intestinal absorption of levothyroxine.
Concomitant
administration of levothyroxine with oral iron preparations, calcium, proton
pump inhibitors and ciprofloxacin may affect the absorption of levothyroxine.
Other drugs may affect the transport and metabolism of levothyroxine; such
effects are produced by phenytoin, carbamazepine, estrogens and rifampin. This
patient was not receiving any of the listed medications. On reviewing the drug
prescription, it became apparent that the patient received levothyroxine just
before breakfast (Table 2).
Food may interfere
with levothyroxine's absorption; it is mandatory that the drug is administered
1-2 hours before the meals. After advancing the time of levothyroxine
administration to 6 a.m., i.e. two hours before breakfast, the response was favourable
(Table 3).
The message is
evident: interference of levothyroxine absorption by food should be avoided by
taking the hormone 1-2 hours before the meals.
Case 9: Preseptal
cellulitis A 58-year-old man, in an unaware wakefulness state following out of
hospital resuscitation, was nursed in our institution during the last 7 years.
On February 2014 the patient's left eyelids and adjacent skin appeared inflamed
and swollen (Figure 4). The temperature was normal and the patient's general
condition appeared not to be affected. We referred the patient for
ophthalmologic consultation. He was diagnosed with preseptal cellulitis and
advised to be treated with amoxicillin-clavulanate. Within two days the
erythema and swelling remitted. Antibiotics were continued for another 5 days.
On February 2019 there was recurrence of the disorder on the same side (Figure
5). With the lesson learned the patient was treated in loco. He made an
uneventful recovery.
Preseptal cellulitis
(sometimes called periorbital cellulitis) is an infection of the eyelid and
surrounding tissue, not involving the orbit or other ocular structures. It is
caused by extension of an extraocular infection or infection through a
superficial breakdown of the skin. Serious complications are very rare.
Preseptal cellulitis usually responds quickly to systemic antibiotics:
clindamycin or TMP-SMX plus one of the following amoxicillin or
amoxicillin-clavulanic acid. Topical antibiotics have no role in the treatment
of this infection [36]. Vaguely resembling preseptal cellulitis, orbital
cellulitis is an infection involving the contents of the orbit (adipose tissue
and ocular muscles). Orbital cellulitis is caused by extension to the orbit of
an adjacent rhinosinusitis, infection of the teeth, middle ear or face,
dacryocystitis, or an infected mucocele eroding into the orbit. Orbital trauma
and ophthalmic surgery can also complicate with orbital cellulitis. Orbital
cellulitis causes pain on eye movements, presence of proptosis, ophthalmoplegia
and diplopia. While preseptal cellulitis is generally a mild condition that
rarely leads to serious complications, orbital cellulitis may cause septic
optic neuritis, intracranial spread, cavernous sinus thrombosis, and cause loss
of vision and even loss of life [37]. It is rare for untreated preseptal
cellulitis to extend into the orbit. In case of doubt, computed tomography of
the orbits and sinuses may distinguish preseptal from orbital cellulitis.
Preseptal cellulitis
typically responds rapidly and completely to appropriate antibiotics. Orbital
cellulitis necessitates urgent referral to the ophthalmic surgeon.
Case 10: Priapism due to
penile metastases A 66-year-old man was admitted for palliative hospice care.
Five years previously he underwent partial resection of the colon for rectal
adenocarcinoma. Pulmonary and retroperitoneal metastases responded initially to
chemotherapy. Lately the disease became refractory to treatment. The patient's
medications included high dose oral morphine, metoclopramide, gabapentin,
zopiclone, amitriptyline and tamsulosin. There was need for permanent bladder
catheterization. At the time of admission to our ward the patient was
cachectic. Numerous subcutaneous nodules were palpable in the abdominal wall.
The penis was stiff in partial erection (Figure 6).
Malignant priapism
was diagnosed. A review of the literature in 2016 acknowledged 512 case reports
[38]. The primary tumor sites were the bladder, prostate and rectum. According
to another review [39], the median survival time after diagnosis of penile
metastasis was 10 months (range 6-18 months). Priapism caused by metastases
from non-urologic tumors (the case in the present patient) had a worse
prognosis. Nonischemic priapism portends no loss of tissue. The glans penis is
usually not engorged. Given the dismal prognosis, palliative noninvasive
treatment is advisable. The urology consultant diagnosed in this patient
priapism by lymph stasis due to neoplastic lymph nodes invasion. Decompression
with elastic bandages was an effective palliation, reducing penile pain and
tumefaction over the patient's remaining two months of life.
3. Discussion
Ten case histories
illustrate the complexity of morbidities not infrequent in patients with
life-limiting conditions. Patients with any serious illness deserve symptomatic
management but also supportive care. Effective collaboration between
disciplines improves patient outcomes, is cost effective, and has the broad
support of clinical research and treatment guidelines [40,41]. In our
experience, collaboration between the internist and oncologist was much
rewarding. Consultation with the palliative medicine specialist was implemented
occasionally.
4. Acknowledgement
There are no grants
or funding for this work. There are no conflicts of interest concerning this
work.
Figure 1: Bedside postural
testing with the patient wearing elastic bandages on her calves and thighs. A
significant decrease in blood pressure is noticed on assuming the seated
position, and a brisk further decline upon standing, necessitating immediate
termination of the test. A: supine, B: sitting, C: standing.
Figure 2: Blood pressure and
heart rate under treatment. A: supine measurements before intake of
medications, B: after intake of midodrine and fludrocortisone measurements in
sitting position in postprandial state.
Figure 3: The patient's
concentration is visible during attempts to propel the bolus within the mouth.
A snapshot of the plate taken thirty minutes after beginning the meal shows
little progress.
Figure 4: Left eye preseptal
cellulitis, 2014.
Figure 5: Left eye preseptal
cellulitis recurrence, 2019.
Figure 6: Partially erected
penis. One among several adjacent enlarged lymph nodes is visible in the
picture under the patient's emaciated hand.
Date |
17/2 |
25/6 |
21/7 |
10/8 |
11/8 |
TSH (0.5-4.8 mlu/L) |
11.3 |
7.6 |
95.6 |
141 |
|
FT3 (3.5-6.5 pmol/L) |
2.3 |
2.2 |
1.96 |
1.65 |
|
T4 (10.3-19 pmol/L) |
12.4 |
15.8 |
10.1 |
8.7 |
|
L- thyroxine dose (mcg) |
100 |
100 |
250 |
250 |
250 |
Date |
17/2 |
25/6 |
21/7 |
10/8 |
TSH (0.5-4.8 mlu/L) |
11.3 |
7.6 |
95.6 |
141 |
FT3 (3.5-6.5 pmol/L) |
2.3 |
2.2 |
1.96 |
1.65 |
T4 (10.3-19 pmol/L) |
12.4 |
15.8 |
10.1 |
8.7 |
L- thyroxine dose (mcg) |
100 |
100 |
250 |
250 |
Time of day (a.m) |
? |
6 |
8 |
8 |
Date |
10/8 |
15/8 |
24/8 |
24.3.2015 |
|
TSH (0.5-4.8 mlu/L) |
141 |
73.6 |
21.7 |
10 |
|
FT3 (3.5-6.5 pmol/L) |
1.65 |
3.38 |
|||
T4 (10.3-19 pmol/L) |
8.7 |
16 |
21.8 |
||
L- thyroxine dose (mcg) |
250 |
250 |
250 |
200 |
150 |
Time of day (a.m) |
8 |
6 |
6 |
6 |
6 |
- Kelley AM, Morrison RS (2015) Palliative care for the
seriously ill. N Engl J Med 373: 747-755.
- Davis MP, Gutgsell T, Gamier P (2015) What is the
difference between palliative care and hospice care? CCJM 82: 569-571.
- Allen LA, Stevenson
LW (2019) Management of patients with cardiovascular disease approaching end of
life. In: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 31:
589-595.
- Ashraf W, Farrow LJ (1992) Severe orthostatic hypotension
in carcinoma of the pancreas. Br J Clin Pract 46: 278-279.
- Niwano F, Hiromine Y, Noso S, Babaya N, Ito H, et al.
(2018) Insulin deficiency with and without glucagon: A comparative study
between total pancreatectomy and type 1 diabetes. J Diabetes Investig 9: 1084-1090.
- McGregor A, Kleiner D (2018) Use of an Insulin Pump in the
Elderly Surgical Patient: Tolerance of Total Pancreatectomy After Neoadjuvant
Chemotherapy for Multifocal Pancreatic Cancer. J Pancreat Cancer 4: 72-74.
- Rao AS, Camilleri M (2010) Review article: metoclopramide
and tardive dyskinesia. Aliment Pharmacol Ther 31: 11-19.
- Dahl E, Diskin AL (2014) Long-lasting adverse effects
after short-term low-dose treatment with metoclopramide for vomiting. Int Marit
Health 65: 16-19.
- Schwartz M, Moguillansky L, Lanyi G, Sharf B (1990) Sulpiride
in tardive dyskinesia. J Neurol Neurosurg Psychiatry 53: 800-802.
- Naschitz JE, Kozel I, Nemoy A, Wolfson T, Leibovitz G
(2016) Chronic feeding intolerance: management in geriatric palliative care. J
Case Reports.
- Nussbaum MS, McFadden DW (2019) Gastric, duodenal, and
small intestinal fistulas. In: Shackelford's Surgery of the Alimentary Tract,
Chapter 76, Pg No: 886-907.
- Naschitz JE (2019) Dehydration Prevention and Diagnosis: A
Study in Long-Term Geriatric and Palliative Care. J Geriatr Med Gerontol 5: 070.
- Young GB (2013) Encephalopathy of infection and systemic
inflammation. J Clin Neurophysiol 30: 454-461.
- Molnár L, Fülesdi B, Németh N, Molnár C (2018) Sepsis-associated
encephalopathy: A review of literature. Neurol India 66: 352-361.
- Bender A, Jox RJ, Grill E, Straube A, Lulé D (2015)
Persistent vegetative state and minimally conscious state: a systematic review
and meta-analysis of diagnostic procedures. Dtsch Arztebl Int 112: 235-242.
- Sankowski R, Mader S, Valdés-Ferrer SI (2015) Systemic
inflammation and the brain: novel roles of genetic, molecular, and
environmental cues as drivers of neurodegeneration. Front Cell Neurosci 9: 28.
- Lu SH, Chen YC, Chang YC, Yen CJ, Dai YT (2013) Effect of
age on febrile response in patients with healthcare-associated bloodstream
infection. Geriatr Nurs 34: 366-372.
- Teale EA, Iliffe S,Young JB (2014) Subdural haematoma in
the elderly. BMJ 342: 1682.
- Baillargeon J, Holmes HM, Lin Y-L Raji MA, Sharma G, et
al. (2012) Concurrent use of warfarin and antibiotics and the risk of bleeding
in older adults. Amer J Med 125: 183-189.
- Krishnan V, Leung LY, Caplan LR (2014) A neurologist's
approach to delirium: Diagnosis and management of toxic metabolic
encephalopathies Eur J Intern Med 25: 112-116.
- Saczynski JS, Marcantonio ER, Quach L, Fong TG, Gross A, et
al. (2012) Cognitive trajectories after postoperative delirium. N Engl J Med 367:
30-39.
- Davidson JE, Harvey MA, Bemis-Dougherty A, Smith JM,
Hopkins RO (2013) Implementation of the Pain, Agitation, and Delirium Clinical
Practice Guidelines and promoting patient mobility to prevent post-intensive
care syndrome. Crit. Care Med 41: 136-145.
- Martino R, Foley N, Bhogal S, Diamant N, Speechley M, et
al. (2005) Dysphagia after stroke: incidence, diagnosis, and pulmonary
complications. Stroke 36: 2756-2763.
- Smithard DG (2016) Dysphagia management and stroke units.
Curr Phys Med Rehabil Rep 4: 287-294.
- Schimmel M, Ono T, Lam OL, Müller F (2017) Oro-facial
impairment in stroke patients. J Oral Rehabil 44: 313-326.
- Banks MD, Graves N, Bauer JD, Ash S (2010) The costs
arising from pressure ulcers attributable to malnutrition. Clin Nutr 29: 180-186.
- Casaer MP, Van den Berghe G (2014) Nutrition in the acute
phase of critical illness. N Engl J Med 370: 1227-1236.
- Cox J, RasmussenL (2014) Enteral nutrition in the
prevention and treatment of pressure ulcers in adult critical care patients.
Crit Care Nurse 34: 15-27.
- Langer G, Fink A (2014) Nutritional interventions for
preventing and treating pressure ulcers. Cochrane Database Syst Rev 6: CD003216.
- Gomes F, Schuetz P, Bounoure L, Austin P,
Ballesteros-Pomar M, et al. (2018) ESPEN guidelines on nutritional support for
polymorbid internal medicine patients. Clin Nutr 37: 336-353.
- Capatina C, Paluzzi A, Mitchell R, Karavitaki N (2015) Diabetes
insipidus after traumatic brain injury. J Clin Med 4: 1448-1462.
- Gelbenegger G, Buchtele N, Schoergenhofer C, Roeggla M,
Schwameis M (2017) Severe Hypernatraemic Dehydration and Unconsciousness in a
Care-Dependent Inpatient Treated with Empagliflozin. Drug Saf Case Rep 4: 17.
- Halbgewachs C, Domes T (2015) Postobstructive diuresis:
pay close attention to urinary retention. Can Fam Physician 61: 137-142.
- Gessi A, Raber W, Nowotny P, Vierhapper H (2000) Spuriously
high serum concentrations of TSH due to the use of an automatic pipetting
device. Exp Clin Endocrinol Diabetes 108: 510-512.
- Srinivas V, Ovibo SO (2010) Levothyroxine
pseudomalabsorption and thyroxine absorption testing with use of high-dose
levothyroxine: case report and discussion. Endocr Pract 16: 1012-1015.
- El Mograbi A, Ritter A, Najjar E, Soudry E (2019) Orbital
Complications of Rhinosinusitis in the Adult Population: Analysis of Cases
Presenting to a Tertiary Medical Center Over a 13-Year Period. Ann Otol Rhinol
Laryngol 128: 563-568.
- Chang YS, Chen PL, Hung JH, Chen HY, Lai CC, et al. (2017)
Orbital complications of paranasal sinusitis in Taiwan, 1988 through 2015:
Acute ophthalmological manifestations, diagnosis, and management. PLoS One. 12:
0184477.
- De Luca F, Zacharakis E, Shabbir M, Maurizi A, Manzi E, et
al. (2016) Malignant priapism due to penile metastases: Case series and
literature review - Arch Ital Urol Androl 88: 150-152.
- Cocci A, Hakenberg OW, Cai T, Nesi G, Livi L, et al. (2018)
Prognosis of men with penile metastasis and malignant priapism: a systematic
review. Oncotarget 92: 2923-2930.
- Finn L, Green AR, Malhotra S (2017) Oncology and Palliative Medicine: providing comprehensive care for patients with cancer. Ochsner J 17: 393-397.
- Ostgathe C, Wendt KN, Heckel M, Kurkowski S, Klein C, et al. (2019) Identifying the need for specialized palliative care in adult cancer patients - development and validation of a screening procedure based on proxy assessment by physicians and filter questions. BMC Cancer 19: 646.